TrialDiabetes care2025

Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial.

Neda Rasouli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.